GlassScriptPhysician profile
Jon David Kannensohn
NPI 1760583587
$580.45
in general payments reported to CMS, 2019-2025
14 companies · $117 in 2025
The $117 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.37 · 2020: $29.51 · 2021: $78.21 · 2022: $65.59 · 2023: $63.10 · 2024: $158 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $102.90 | 2019-2025 | |
| Sobi, INC | $80.68 | 2019-2023 | |
| Corium, LLC | $70.25 | 2024 | Azstarys, Azstarys |
| Glaxosmithkline, LLC. | $61.74 | 2019-2024 | Bexsero |
| Merck Sharp & Dohme LLC | $46.37 | 2021-2022 | |
| Sanofi Pasteur INC. | $33.28 | 2023-2024 | |
| Cranial Technologies, INC | $32.66 | 2023-2024 | Doc Band |
| Cipher Pharmaceuticals US LLC | $28.09 | 2025 | Natroba, Spinosad |
| Kowa Pharmaceuticals America, INC. | $27.97 | 2024-2025 | Zoryve |
| Kaleo, INC. | $24.11 | 2019-2023 | Auvi-Q |
| Ironshore Pharmaceuticals INC. | $21.99 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $19.59 | 2022 | |
| Supernus Pharmaceuticals, INC. | $17.16 | 2025 | Qelbree |
| Ars Pharmaceuticals Operations, INC. | $13.66 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Kannensohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.